FaF:FACD3_13 Diploma Thesis III - Course Information
FACD3_13 Diploma Thesis III
Faculty of PharmacySpring 2024
- Extent and Intensity
- 0/20/0. 20 credit(s). Type of Completion: z (credit).
- Guaranteed by
- doc. PharmDr. Kateřina Kubová, Ph.D.
Department of Pharmaceutical Technology – Departments – Faculty of Pharmacy - Prerequisites (in Czech)
- FAKULTA(FaF) || OBOR(MUSFaF)
- Course Enrolment Limitations
- The course is only offered to the students of the study fields the course is directly associated with.
- fields of study / plans the course is directly associated with
- Pharmacy (programme FaF, M-FARMA)
- Course objectives
- The subject aims to guide the students during the working out of their diploma thesis, to help them to search and analyse the relevant literature sources, to learn the scientific research methods of the chosen field, the principles of scientific and publication ethics, and the correct and effective presentation of the results of their own scientific work.
- Learning outcomes
- After attending the subject the student will be able to:
-search relevant professional literature sources and work out its results;
-apply the learned scientific research methods to obtain data;
-process and analyze the obtained data;
-work out a comprehensive professional text and adequately present the results of own work - Syllabus
- 1. Research and study of the recommended literature. 2. Defining the aims of the thesis. 3. Choosing the relevant working methods. 4. Testing the methods. 5. A pilot study. 6. Obtaining and processing the results. 7. Discussion of the results. 8. Conclusions and recommendations.
- Literature
- Teaching methods
- theoretical study, consultation, brainstorming, discussion, individual work
- Assessment methods
- Basic requirement for recording the credits is submitting the final diploma thesis.
- Language of instruction
- English
- Further Comments
- The course can also be completed outside the examination period.
- Enrolment Statistics (recent)
- Permalink: https://is.muni.cz/course/pharm/spring2024/FACD3_13